Rare diseases
Investigational molecules
Locations
147 conditions with trials, the busiest first
548 trials across Europe, recruiting first
Study on the Effectiveness and Safety of KarXT for Treating Psychosis in Patients with Alzheimer's Disease
BelgiumStudy on Ketamine and Midazolam for Adults with Depression and Alcohol Use Disorder
NorwayStudy on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants
BulgariaStudy on Baclofen for Reducing Benzodiazepine Use in Patients with Benzodiazepine Dependence
FranceStudy Comparing Cytisinicline and Nicotine Therapy for Patients with Nicotine Dependence and Chronic Kidney Disease
PolandStudy on Dexamfetamine for Adults with Amphetamine and Opioid Dependence Undergoing Opioid Treatment
NorwayStudy Comparing Lithium and Lamotrigine for Mood Stabilization in Patients with Bipolar Disorder Type II
DenmarkStudy on Fluasterone for Managing High Blood Sugar in Adults with Cushing's Syndrome
GreeceStudy on Nitrous Oxide and Oxygen for Treating Depression in Nursing Home Residents with Neurocognitive Disorders
FranceStudy on Treating Anemia After Cesarean with Ferric Carboxymaltose or Oral Iron in Women with Moderate Iron Deficiency Anemia
FranceStudy on Ketamine and CBASP for Treating Chronic Depression in Adults
GermanyStudy on MDMA-Assisted Therapy for Patients with Treatment-Resistant PTSD
The NetherlandsThe therapies tested most often in Psychiatric disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
